Live from the NIH registry
Studies recruiting near Asheville right now
Top 25 of 124 recruiting studies, sorted by proximity — each links to its official registry page
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
Graves' Disease
Phase 2
Interventional 240 participants sought
Site Number - 1051 — Asheville, North Carolina (2.1 mi)
· Sponsor: Immunovant Sciences GmbH
RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures
Focal Onset Seizures
Phase 2
Interventional 216 participants sought
Asheville Neurology Specialists — Asheville, North Carolina (2.1 mi)
· Sponsor: Supernus Pharmaceuticals, Inc.
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Non Small Cell Lung Cancer, c-MET
Phase 3
Interventional 768 participants sought
AdventHealth Hendersonville /ID# 265349 — Hendersonville, North Carolina (18.2 mi)
· Sponsor: AbbVie
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
Phase 3
Interventional 762 participants sought
89bio Clinical Study Site — Asheville, North Carolina (2.1 mi)
· Sponsor: 89bio, Inc.
A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer
Metastatic HER2-positive Breast Cancer
Phase 3
Interventional 550 participants sought
Messino Cancer Center — Asheville, North Carolina (2.1 mi)
· Sponsor: Jazz Pharmaceuticals
A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
Parkinson Disease
Phase 2
Interventional 150 participants sought
Asheville Neurology Specialists, P.A. (Site #229) — Asheville, North Carolina (2.1 mi)
· Sponsor: Appello Pharmaceuticals, Inc.
Sequential and Comparative Evaluation of Pain Treatment Effectiveness Response
Chronic Low Back Pain
N/A
Interventional 2,529 participants sought
Asheville VA Medical Center, Asheville, NC — Asheville, North Carolina (2.1 mi)
· Sponsor: VA Office of Research and Development
Reducing Fluid Overload in Heart Failure Patients Using a Non-invasive, Renal Independent System
Chronic Heart Failure, CKD Stage 3
N/A
Interventional 40 participants sought
Mission Hospital — Asheville, North Carolina (2.1 mi)
· Sponsor: AquaPass Medical Ltd.
Multi-Center Study of Clinical and Inflammatory Outcomes in Intensive Cardiac Rehabilitation and Traditional Cardiac Rehabilitation Programs
Cardiovascular Diseases
N/A
Interventional 450 participants sought
Mission Health — Asheville, North Carolina (2.1 mi)
· Sponsor: Pritikin ICR
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Phase 3
Interventional 247 participants sought
Margaret R Pardee Memorial Hospital — Hendersonville, North Carolina (18.2 mi)
· Sponsor: National Cancer Institute (NCI)
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Cardiovascular Risk, Acute Myocardial Infarction (AMI)
Phase 3
Interventional 10,000 participants sought
Cardiology Associates_Asheville — Asheville, North Carolina (2.1 mi)
· Sponsor: Novo Nordisk A/S
Alleviant ALLAY-HFrEF Study
Heart Failure
N/A
Interventional 350 participants sought
Mission Hospital — Asheville, North Carolina (2.1 mi)
· Sponsor: Alleviant Medical, Inc.
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
Malignant Solid Neoplasm
N/A
Observational 2,062 participants sought
AdventHealth Infusion Center Asheville — Asheville, North Carolina (2.1 mi)
· Sponsor: SWOG Cancer Research Network
Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1
Focal Seizure, Epilepsy
Phase 3
Interventional 333 participants sought
Asheville Neurology Specialists — Asheville, North Carolina (2.1 mi)
· Sponsor: Rapport Therapeutics Inc.
Exactech Shoulder Post Market Clinical Follow-up Study
Osteo Arthritis Shoulders, Osteonecrosis
N/A
Observational 20,000 participants sought
Southeastern Sports Medicine and Orthopedics — Asheville, North Carolina (2.1 mi)
· Sponsor: Exactech
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
Geographic Atrophy, Macular Degeneration
Phase 2, Phase 3
Interventional 274 participants sought
Asheville Eye Associates - Western Carolina Retinal Associates — Asheville, North Carolina (2.1 mi)
· Sponsor: Janssen Research & Development, LLC
A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
Type 1 Diabetes Mellitus
Phase 3
Interventional 723 participants sought
Asheville Clinical Research- Site Number : 8400045 — Asheville, North Carolina (2.1 mi)
· Sponsor: Sanofi
Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy
Diabetic Peripheral Neuropathic Pain
Phase 3
Interventional 734 participants sought
Asheville Clinical Research — Asheville, North Carolina (2.1 mi)
· Sponsor: Vertex Pharmaceuticals Incorporated
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Anaplastic Kidney Wilms Tumor, Recurrent Kidney Wilms Tumor
Phase 2
Interventional 256 participants sought
Mission Hospital — Asheville, North Carolina (2.1 mi)
· Sponsor: Children's Oncology Group
Alleviant ALLAY-HF Study
Heart Failure
N/A
Interventional 700 participants sought
Mission Hospital — Asheville, North Carolina (2.1 mi)
· Sponsor: Alleviant Medical, Inc.
Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
Colorectal Cancer Stage II, Colorectal Cancer Stage III
Phase 3
Interventional 1,057 participants sought
Margaret R Pardee Memorial Hospital — Hendersonville, North Carolina (18.2 mi)
· Sponsor: SWOG Cancer Research Network
Virtue® SAB in the Treatment of Coronary ISR Trial
Coronary Artery Disease
N/A
Interventional 740 participants sought
Mission Hospital — Asheville, North Carolina (2.1 mi)
· Sponsor: Orchestra BioMed, Inc
SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
Type 1 Diabetes
Phase 2
Interventional 159 participants sought
Asheville Clinical Research — Asheville, North Carolina (2.1 mi)
· Sponsor: SAb Biotherapeutics, Inc.
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)
Macular Degeneration, Age-Related Macular Degeneration
Phase 2, Phase 3
Interventional 960 participants sought
Asheville Eye Associates, Retina Division (Site 077) — Asheville, North Carolina (2.1 mi)
· Sponsor: EyeBiotech Ltd.
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Mission Hospital — Asheville, North Carolina (2.1 mi)
· Sponsor: National Cancer Institute (NCI)